Skip to content
Entertainment, Medical Health Aged Care

Australians support restricting alcohol exposure in films for kids

La Trobe University 2 mins read

Most Australian adults support the use of policies to restrict the depiction of alcohol in films aimed at children under the age of 15, a new study by La Trobe University researchers shows.

Alcohol exposure is common in popular films and research has demonstrated a link between alcohol exposure and use. Currently, only alcohol marketing in films is regulated – but not alcohol exposure, such as seeing an alcoholic beverage.

Researchers from the La Trobe University Centre for Alcohol Policy Research launched a study to see how supportive people were of eight potential policies, and whether people would be more supportive of restrictions if they received information about how much alcohol was actually in popular films.

Led by PhD candidate Maree Patsouras, the study, published in Drug and Alcohol Review, found all participants were supportive of four of the eight proposed policies, but two in particular.

“Policies such as not showing alcoholic beverages or alcohol use in films recommended towards children under 15, and not glorifying alcohol consumption / alcoholic beverages, were the most supported policies in the study,” Ms Patsouras said.

The study involved 252 Australian adults aged 18-75, who provided an estimate of how much alcohol they thought was in popular films at the start of the study, and then randomly placed into two groups. One group was shown an infographic outlining the actual amount of alcohol in films, to determine if this would impact their views of the policies.

The participants were asked to rate their support of eight policies aimed at addressing alcohol consumption in films.

Those who were older, female or reported lower alcohol use were more supportive of the policies.

The policies supported by the majority of people were:

  • Alcoholic beverages and consumption should not be shown in G or PG rated films
  • Alcohol should not be glorified in films

The researchers said this was consistent with previous Australian research showing that obvious or prominent alcohol consumption should not be featured in films targeted towards children under 15 years of age.

“Consistently, participants in our study may have endorsed support for these items because they represented basic regulations they believed were important and were already in place. For example, G film classifications may be considered a ‘proxy’ for suitable children content, without awareness of actual exposure amounts,” the study found.

 

The two policies with lowest support were:

  • Alcoholic beverages should not be shown within any film, regardless of classification
  • At the beginning of each film, information should be provided about how much alcohol the film contains.

 

The study found that males/other, those who reported more drinking, and younger participants, were less supportive of the policies.

 

The only policy that received higher support from the intervention group that received the infographic was: “Information about alcohol sponsorship should be provided”.

The study concluded: “Participants were generally supportive of various public health-oriented film-specific alcohol policies … which was particularly the case for older, less heavy drinking, and female participants.

“Providing information about how much alcohol was in popular films was related to more support that there should be information about industry sponsorship at the start of the film but did not affect other policies or the overall policy score.”

The full paper, Support for policies restricting alcohol exposure in films: Does feeding back the amount of alcohol in films increase support?, has been published in Drug and Alcohol Review.

 

DOI: https://doi.org/10.1111/dar.13756

 

Interview requests

 

Maree Patsouros

m.patsouras@latrobe.edu.au

 

La Trobe media team

Media@latrobe.edu.au

T: 0404 030 698

More from this category

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 15:35
Health Services Union

Minns ministers must stop misleading on paramedic pay

The Minns government is misleading the public with deliberately inflated figures about what paramedics are paid, as it risks mass resignation and deregistration of one of its most skilled but underpaid workforces.In a note circulated to media, the Government has claimed its pay offer would lift a first year paramedic’s take home pay from $123,594 to $137,683.This is not a figure that has been put to the HSU and nor it accurate. The offer put to the Union proposes a paltry 11.4 per cent, four year increase to the base pay of first year paramedics, from $74,364 to $82,877.The so-called…

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 14:11
Health Equity Matters

Darryl O’Donnell steps down as CEO of Health Equity Matters

Health Equity Matters pays tribute to chief executive officer, Adjunct Professor Darryl O’Donnell, who is stepping down after eight impactful years leading the organisation. Health Equity Matters president, Mark Orr AM, said O’Donnell had been a transformative leader. “Darryl became chief executive at a very challenging time for the organisation. In the years since, he has worked tirelessly to enhance its stability and sustainability. This has expanded our capacity and impact. “Among his many achievements, Darryl has most recently helped shape the work of the HIV Taskforce chaired by the Hon Mark Butler MP, and the LGBTIQA+ Health Ten Year…

  • Medical Health Aged Care
  • 08/12/2023
  • 12:07
EnGeneIC

EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic

SYDNEY, Australia and NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- EnGeneIC, an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology, has achieved a significant milestone with the granting of FDA “Fast-Track” designation for its pancreatic cancer therapeutic. This approval underscores the potential of EnGeneIC’s unique approach to revolutionise pancreatic cancer treatment.Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative treatment options limited.The FDA’s decision to grant “Fast-Track” status reflects the urgency and unmet medical need associated with PDAC. EnGeneIC’s EDVTM (EnGeneIC Dream Vector) has…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.